Idarubicin 10mg/10mL
| Product Overview | |
| Generic Name | Idarubicin 10mg/10mL |
| Brand Name(s) | Idamycin, Zavedos |
| Form | Injection (solution 1 mg/mL in single-dose vials) |
| Strength | 10mg/10mL vial |
| Therapeutic Class | Anthracycline antitumor antibiotic |
| ATC Code | L01DB06 |
| Manufacturing & Regulatory | |
| Manufacturer | Various |
| Country | Mexico, India, USA |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.4434.00 |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 10 Vials |
| Shelf Life | 24 months |
| Storage | Injection (solution) commonly stored 2–8 °C, protect from light |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Supplied per batch upon request |
Description
Idarubicin is an anthracycline cytotoxic chemotherapy used primarily in acute myeloid leukemia (AML/LMA), commonly as part of combination induction regimens.
